Y8U-29662-63458
4 vaccinations
5 coded responses
37 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 549 / WI
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-11
Dose 2 — Pfizer-BioNTech
-
2021-02-24
Survey response — day 7, dose 2MedDRA: Chills, Decreased appetite, Fatigue, Injection site pain, Injection site swelling, Lymphadenopathy — Feeling: GoodFree text: Day after 2nd shot: chills, exhaustion, no appetite, sir and swollen injection site; 2nd day after shot: swollen lymph node in armpit of injection site armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
- 2021-08-12
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Lymph node in armpit of injection site arm later in 1st and 2nd day(today); all other symptoms better today, 2nd dayMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: SwellingFree text: Lymph node swelling not completely gone yetMedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
-
2022-01-04
Survey response — 3 months, dose 3MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had Influenza AMedDRA releases: 2024-11 · check-in free text available
- 2022-04-05
-
2022-04-26
Dose 4 — Pfizer-BioNTech
- 2022-05-15
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-07-26
-
2022-10-25
Survey response — 6 months, dose 4MedDRA: Cough, Exposure to SARS-CoV-2, Fatigue, Lymphadenopathy, Nasopharyngitis, Pyrexia, Reaction to previous exposure to any vaccine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got booster when had apparently already been exposed to Covid but had no symptoms to indicate. Always have 3 day reactions to booster (fever, swollen lymph node, cough, fatigue) then spun into notable cold-like Covid symptomsMedDRA releases: 2024-11 · check-in free text available
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-04-26 | Pfizer-BioNTech | No |
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Day after 2nd shot: chills, exhaustion, no appetite, sir and swollen injection site; 2nd day after shot: swollen lymph node in armpit of injection site arm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node in armpit of injection site arm later in 1st and 2nd day(today); all other symptoms better today, 2nd day
Systemic reaction (other): Lymph node swelling not completely gone yet
Release 10 — 3 months, dose 3
Symptoms: Had Influenza A
Release 12 — 6 months, dose 4
Symptoms: Got booster when had apparently already been exposed to Covid but had no symptoms to indicate. Always have 3 day reactions to booster (fever, swollen lymph node, cough, fatigue) then spun into notable cold-like Covid symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release